Melanoma
Reviews
Key issues in the management of gastrointestinal immune-related adverse events associated with ipilimumab administration
Article
Anti-PD-1 antibodies in melanoma
News
Thiopurine use ups risk of skin cancer for ulcerative colitis patients
Major Finding: Current users of thiopurines had more than twice the risk of nonmelanoma skin cancer as never users (hazard ratio, 2.1), but former...
News
Low-intensity chemo works for Burkitt’s lymphoma
Major Finding: At median follow-ups of 86 and 73 months, respectively, the HIV-negative group had a 95% rate of freedom from disease progression...
News
Ipilimumab’s long-term survival edge confirmed in melanoma
Major finding: Median overall survival was 11.4 months and 3-year survival 22% among 1,861 patients receiving ipilimumab in clinical trials.Data...
News
Inpatient dermatologist offers three rules to diagnose by
News
Vismodegib prolongs positive response in advanced skin cancer
Major finding: With an additional 24 months of follow-up of vismodegib-treated patients with advanced basal cell carcinoma beyond previous results...
News
Poor oral health a risk factor in oncogenic HPV infection
Major finding: Poor oral health was associated with a 56% higher prevalence of oral infection with human papillomavirus.Data source: A nationally...
News
Illinois bans tanning beds for youngsters
News
Selumetinib is first therapy to shrink uveal melanomas
Major finding: Tumors regressed in 11% (RECIST response, 0%) of 46 evaluable patients in the temozolomide arm and in 50% (RECIST response, 15%) of...
News
Nivolumab activity is durable in advanced melanoma
Major finding: Median overall survival across all doses of nivolumab was 16.8 months.